PRRT2 and subarachnoid hemorrhage: Furthermore, in vivo rat studies demonstrated that PKC inhibitors prevent the upregulation of vascular endothelin receptors and reverse the reduction of cerebral blood flow subsequent to subarachnoid hemorrhage [43].